Purchase Order 75N90024P00539
- Not listed
- This firm fixed-price purchase order was awarded by the National Institutes of Health (NIH) Clinical Center to Illumina, Inc., a manufacturer of genetic and genomic analysis instruments and reagents. The $24,942.05 contract is for the delivery of a kit that will be used in cell products made by Illumina for a single-cell gene and protein expression assay. The award does not have a set-aside designation. Based on Illumina's past federal contracting history, the company has provided a range of...
- This is a firm fixed price delivery order awarded by the National Institutes of Health (NIH) Clinical Center to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $22,198.05 contract is for the provision of various Illumina sequencing systems, reagents, consumables, and related services to support genomic sequencing and analysis work. Illumina has a history of providing similar products and services to federal agencies like the NIH,...
- This is a firm fixed-price delivery order contract awarded to Illumina, Inc., a biotechnology company headquartered in San Diego, California. The $12,836.50 contract was awarded by the National Institutes of Health (NIH) Clinical Center, a civilian federal agency, on September 24, 2025 with an ultimate completion date of October 23, 2025. The contract does not utilize any set-aside designations. Illumina, a for-profit manufacturer of goods, will provide the NIH with various genomic sequencing...
- This is a firm fixed price delivery order awarded by the National Institutes of Health (NIH) Clinical Center to Illumina, Inc. for the provision of Illumina reagent kits. The order, valued at $52,407.45, has a period of performance through September 30, 2024. There was no set-aside designation for this award. Based on Illumina's prior federal contract work, the company has provided a range of genomic sequencing instruments, reagents, and related services to support research and diagnostics...
- This is a firm fixed price purchase order awarded by the National Institute of Child Health and Human Development, a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc. for $80,547.47 to provide Illumina reagent kits. The award has a ceiling value of $81,551.80 and an ultimate completion date of September 30, 2024. This purchase order was issued under a Special Notice solicitation that was not set aside for any specific business category. Illumina is a...
- This is a firm fixed price delivery order awarded by the National Institutes of Health (NIH) National Institute of Environmental Health Sciences to Illumina, Inc. for the provision of sequencing reagents. The order, valued at $108,155.85, has an October 30, 2022 completion date. Illumina, a manufacturer of sequencing and genomic analysis instruments and reagents, has previously provided similar products and services to support life science research and molecular diagnostics across federal...
- This is a firm fixed price delivery order awarded by the Department of Health and Human Services' National Institutes of Health (NIH) to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The order, valued at $82,222.31, is for the delivery of various Illumina sequencing systems, reagents, and consumables to support genomic sequencing and analysis research at the National Institute of Environmental Health Sciences. The order was placed...
- This firm fixed-price delivery order was awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $136,783.84 contract is for the provision of Illumina reagent kits to support genomic sequencing and analysis for research and diagnostic purposes. The award has a completion date of August 2, 2023. Illumina...
- This is a $75,560 firm fixed price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Illumina, Inc., a manufacturer of genetic and genomic analysis equipment and reagents. The contract is for the delivery of various Illumina sequencing systems, consumables, and related support services. There is no set-aside designation for this contract. Illumina has a history of supporting genomic sequencing and analysis for federal agencies like the NIH, Centers for...
- This firm fixed-price delivery order was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Child Health and Human Development to Illumina, Inc., a for-profit manufacturer of genetic sequencing systems and consumables. The $161,545.56 award is for the provision of Illumina sequencing kits and reagents to support genomic analysis and research. While no set-aside designation was used, Illumina has an extensive history of providing...
This firm fixed-price purchase order was awarded by the National Institutes of Health (NIH) Clinical Center to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents, for the delivery of Illumina reagent kits to be used for single-cell sequencing analysis of Chimeric Antigen Receptor T-cells (CAR-T cells) at the NIH Clinical Center. The contract, valued at $24,942.05, has an ultimate completion date of August 29, 2024 and does not utilize any set-aside provisions. Illumina is a well-established provider of sequencing solutions to federal agencies, including the NIH, Centers for Disease Control and Prevention, Department of Agriculture, and Department of Veterans Affairs, through both prime contracts and subcontracts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Supplemental Agreement for work within scope | $0 | 7/31/24 | |
| Not listed | Not listed | $24.9k | 7/25/24 |